Suárez, Yajaira

MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 1,260

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C. M., Warrier, N. P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J. C., et al. (2011) · Proceedings of the National Academy of Sciences

MicroRNA in disease regulationCholesterol and Lipid Metabolism

Cited by 670

MicroRNAs in Metabolic Disease

Fernández-Hernando, C., Ramírez, C. M., Goedeke, L., & Suárez, Y. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology

MicroRNA in disease regulationCholesterol and Lipid Metabolism

Cited by 257

MicroRNA-758 Regulates Cholesterol Efflux Through Posttranscriptional Repression of ATP-Binding Cassette Transporter A1

Ramirez, C. M., Dávalos, A., Goedeke, L., Salerno, A. G., Warrier, N., Cirera-Salinas, D., Suárez, Y., & Fernández-Hernando, C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 242

Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144

Ramírez, C. M., Rotllan, N., Vlassov, A. V., Dávalos, A., Li, M., Goedeke, L., Aranda, J. F., Cirera-Salinas, D., Araldi, E., Salerno, A., et al. (2013) · Circulation Research

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 217

MicroRNA 33 Regulates Glucose Metabolism

Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology

MicroRNA in disease regulationMetabolism, Diabetes, and Cancer

Cited by 154

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice

Goedeke, L., Salerno, A., Ramírez, C. M., Guo, L., Allen, R. M., Yin, X., Langley, S. R., Esau, C., Wanschel, A., Fisher, E. A., et al. (2014) · EMBO Molecular Medicine

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 145

A Regulatory Role for MicroRNA 33* in Controlling Lipid Metabolism Gene Expression

Goedeke, L., Vales-Lara, F. M., Fenstermaker, M., Cirera-Salinas, D., Chamorro-Jorganes, A., Ramírez, C. M., Mattison, J. A., de Cabo, R., Suárez, Y., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology

MicroRNA in disease regulationCholesterol and Lipid Metabolism

Cited by 140

Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis

Price, N. L., Rotllan, N., Canfrán-Duque, A., Zhang, X., Pati, P., Arias, N., Moen, J., Mayr, M., Ford, D. A., Baldán, Á., et al. (2017) · Cell reports

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 129

Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice

Singh, A. K., Chaube, B., Zhang, X., Sun, J., Citrin, K. M., Canfrán-Duque, A., Aryal, B., Rotllan, N., Varela, L., Lee, R. G., et al. (2021) · Journal of Clinical Investigation

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 115

Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance

Price, N. L., Singh, A. K., Rotllan, N., Goedeke, L., Wing, A., Canfrán-Duque, A., Diaz-Ruiz, A., Araldi, E., Baldán, Á., Camporez, J.-P., et al. (2018) · Cell Reports

MicroRNA in disease regulationAdipokines, Inflammation, and Metabolic Diseases

Cited by 110

Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells.

Montero, M. T., Hernández, O., Suárez, Y., Matilla, J., Ferruelo, A. J., Martı́nez-Botas, J., Gómez-Coronado, D., & Lasunción, M. A. (2000) · Atherosclerosis

Atherosclerosis and Cardiovascular DiseasesInflammasome and immune disorders

Cited by 97

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

Zhang, X., Rotllan, N., Canfrán-Duque, A., Sun, J., Toczek, J., Moshnikova, A., Malik, S., Price, N. L., Araldi, E., Zhong, W., et al. (2022) · Circulation Research

RNA Interference and Gene DeliveryMicroRNA in disease regulation

Cited by 75

Improved repair of dermal wounds in mice lacking micro RNA‐155

van Solingen, C., Araldi, E., Chamorro‐Jorganes, A., Fernández‐Hernando, C., & Suárez, Y. (2014) · Journal of Cellular and Molecular Medicine

Wound Healing and TreatmentsMicroRNA in disease regulation

Cited by 66

Autoregulation of glypican-1 by intronic microRNA-149 fine-tunes the angiogenic response to fibroblast growth factor in human endothelial cells

Chamorro-Jorganes, A., Araldi, E., Rotllan, N., Cirera-Salinas, D., & Suárez, Y. (2014) · Journal of Cell Science

MicroRNA in disease regulationFibroblast Growth Factor Research

Cited by 57

Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis

Price, N. L., Zhang, X., Fernández-Tussy, P., Singh, A. K., Burnap, S. A., Rotllan, N., Goedeke, L., Sun, J., Canfrán-Duque, A., Aryal, B., et al. (2021) · Proceedings of the National Academy of Sciences

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 50

miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches

Price, N. L., Goedeke, L., Suárez, Y., & Fernández‐Hernando, C. (2021) · EMBO Molecular Medicine

MicroRNA in disease regulationCholesterol and Lipid Metabolism

Cited by 36

microRNA-33 controls hunger signaling in hypothalamic AgRP neurons

Price, N. L., Fernández-Tussy, P., Varela, L., Cardelo, M. P., Shanabrough, M., Aryal, B., de Cabo, R., Suárez, Y., Horvath, T. L., & Fernández-Hernando, C. (2024) · Nature Communications

Regulation of Appetite and ObesityMicroRNA in disease regulation

Cited by 25

miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression

Fernández-Tussy, P., Cardelo, M. P., Zhang, H., Sun, J., Price, N. L., Boutagy, N. E., Goedeke, L., Cadena-Sandoval, M., Xirouchaki, C. E., Brown, W., et al. (2024) · JCI Insight

Liver Disease Diagnosis and TreatmentMicroRNA in disease regulation

Cited by 21